Filteren op Last updated date SelecterenNaVoorFrom - To Datum Einddatum Deze week Deze maand Afgelopen week Afgelopen maand Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Laat dit veld leeg Filter Resultaten (3786) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Laat dit veld leeg Chair of the European Network of Paediatric Research at EMA re-elected 5 oktober 2022 News Medicines Paediatrics Call for expression of interest for civil society representatives to participate in the work of EMA’s Paediatric Committee 5 oktober 2022 News Regulatory information – adjusted fees for pharmacovigilance applications from 3 October 2022 30 september 2022 News Corporate New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome 30 september 2022 News Human Medicines Referrals Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022 30 september 2022 News Human Pharmacovigilance Referrals EMA pilot offers enhanced support to academic and non-profit developers of advanced therapy medicinal products 29 september 2022 News Human Advanced therapies Medicines New co-chairs elected for working parties for healthcare professionals and for patients and consumers 23 september 2022 News Corporate Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2022 22 september 2022 News Human COVID-19 Medicines Biosimilar medicines can be interchanged 19 september 2022 News Human Corporate Biosimilars New medicine to protect babies and infants from respiratory syncytial virus (RSV) infection 16 september 2022 News Human Medicines 1 … 34 35 36 37 38 Page 38 of 379 39 40 41 42 … 379
Chair of the European Network of Paediatric Research at EMA re-elected 5 oktober 2022 News Medicines Paediatrics
Call for expression of interest for civil society representatives to participate in the work of EMA’s Paediatric Committee 5 oktober 2022 News
Regulatory information – adjusted fees for pharmacovigilance applications from 3 October 2022 30 september 2022 News Corporate
New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome 30 september 2022 News Human Medicines Referrals
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022 30 september 2022 News Human Pharmacovigilance Referrals
EMA pilot offers enhanced support to academic and non-profit developers of advanced therapy medicinal products 29 september 2022 News Human Advanced therapies Medicines
New co-chairs elected for working parties for healthcare professionals and for patients and consumers 23 september 2022 News Corporate
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2022 22 september 2022 News Human COVID-19 Medicines
New medicine to protect babies and infants from respiratory syncytial virus (RSV) infection 16 september 2022 News Human Medicines